United Therapeutics UTHR ROW — Total revenues

Similar metrics at other companies

AMGNNon Us — Total revenues

$2.58B+8.1%

MYGNRoW — Revenue

$13.4M-6.3%

VRNSRest of the World — Revenue

$13.34M+7.6%

SLABRest of world — Revenue

$85.57M+18.1%

OMCLRest of world — Total revenues

$31.78M+55.8%

WSRest Of World — Revenue

$29.63M+13.2%

Questions, answered.

What is United Therapeutics's ROW — total revenues?

United Therapeutics (UTHR) reported ROW — total revenues of $37.3M in Q1 2026.

How has United Therapeutics's ROW — total revenues changed year-over-year?

United Therapeutics's ROW — total revenues decreased by 16.7% year-over-year, from $44.8M to $37.3M.

What is the long-term trend for United Therapeutics's ROW — total revenues?

Over 4 years (2021 to 2025), United Therapeutics's ROW — total revenues has grown at a 4.7% compound annual growth rate (CAGR), from $121.3M to $145.7M.

What does ROW — total revenues mean?

This metric represents the total gross revenue generated from sales of pharmaceutical products and services within geographic regions outside of the company's primary domestic market. It serves as a key indicator of the company's international commercial footprint and its ability to penetrate global markets for its specialized therapies. Monitoring this figure helps investors assess the diversification of revenue streams and the success of international regulatory and distribution strategies.